We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+5.79%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$64.7B
AUM Growth
+$5.24B
Cap. Flow
+$2.36B
Cap. Flow %
3.65%
Top 10 Hldgs %
20.54%
Holding
3,821
New
235
Increased
1,962
Reduced
1,317
Closed
186

Top Sells

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$40.1M
2
T icon
AT&T
T
+$28M
3
FTXO icon
First Trust Nasdaq Bank ETF
FTXO
+$24.3M
4
TTE icon
TotalEnergies
TTE
+$23.7M
5
WMT icon
Walmart Inc
WMT
+$22.8M

Sector Composition

Rank Sector Weight
1 Technology 10.68%
2 Financials 9.21%
3 Healthcare 8.48%
4 Industrials 6.92%
5 Consumer Discretionary 5.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVDA icon
76
NVIDIA
NVDA
$5.42T
$168M 0.26%
23,938,360
+1,348,360
+6% +$8.77M
DUK icon
77
Duke Energy
DUK
$97.3B
$166M 0.26%
2,074,246
+555
+0% +$44.9K
GSK icon
78
GSK
GSK
$106B
$166M 0.26%
3,303,298
-56,054
-2% -$2.85M
DIS icon
79
Walt Disney
DIS
$181B
$160M 0.25%
1,370,295
+133,100
+11% +$14.8M
CCI icon
80
Crown Castle
CCI
$32.2B
$156M 0.24%
1,402,315
+14,608
+1% +$1.63M
ABT icon
81
Abbott
ABT
$187B
$153M 0.24%
2,086,882
+101,959
+5% +$6.69M
MDT icon
82
Medtronic
MDT
$112B
$152M 0.24%
1,549,574
+145,046
+10% +$13.4M
GSLC icon
83
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
$15.5B
$149M 0.23%
2,538,797
+308,929
+14% +$17.8M
BIIB icon
84
Biogen
BIIB
$30.7B
$149M 0.23%
421,552
+2,095
+0.5% +$721K
FAST icon
85
Fastenal
FAST
$59.5B
$148M 0.23%
10,232,948
+274,040
+3% +$3.9M
AGN
86
DELISTED
Allergan plc
AGN
$147M 0.23%
773,407
+105,115
+16% +$19.3M
ISTB icon
87
iShares Core 1-5 Year USD Bond ETF
ISTB
$5.13B
$147M 0.23%
2,989,972
+153,484
+5% +$7.52M
AMGN icon
88
Amgen
AMGN
$222B
$146M 0.23%
705,492
-31,321
-4% -$6.17M
MA icon
89
Mastercard
MA
$493B
$144M 0.22%
648,169
+94,873
+17% +$19.8M
VEA icon
90
Vanguard FTSE Developed Markets ETF
VEA
$236B
$144M 0.22%
3,333,951
+85,466
+3% +$3.68M
SPIB icon
91
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$11.5B
$144M 0.22%
4,327,605
+263,859
+6% +$8.79M
ADSK icon
92
Autodesk
ADSK
$52.6B
$140M 0.22%
899,760
+33,531
+4% +$4.73M
MCHP icon
93
Microchip Technology
MCHP
$46B
$139M 0.21%
3,520,556
+155,158
+5% +$6.86M
MMM icon
94
3M
MMM
$94.3B
$137M 0.21%
778,433
+33,225
+4% +$5.72M
USB icon
95
US Bancorp
USB
$99.6B
$137M 0.21%
2,590,473
+101,183
+4% +$5.36M
VOD icon
96
Vodafone
VOD
$37.4B
$135M 0.21%
6,229,702
+366,304
+6% +$8.51M
D icon
97
Dominion Energy
D
$59.3B
$133M 0.21%
1,893,911
-68,050
-3% -$4.82M
BDX icon
98
Becton Dickinson
BDX
$48.2B
$133M 0.21%
521,515
+27,626
+6% +$6.81M
EFA icon
99
iShares MSCI EAFE ETF
EFA
$80.2B
$132M 0.2%
1,946,799
+81,671
+4% +$5.52M
BCE icon
100
BCE
BCE
$21.2B
$127M 0.2%
3,146,925
-92,146
-3% -$3.8M

Similar funds

Raymond James & Associates's Q3 2018 Portfolio in Review

As of Q3 2018, Raymond James & Associates held 3,821 positions worth $64.7B, up 8.8% from $59.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates deployed $2.36B of net new capital in Q3 2018, opening 235 new positions and adding to 1,962 existing holdings. Its largest new stake was State Street Communication Services Select Sector SPDR ETF: 365,478 shares worth $17.9M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Sanofi, an estimated $40.1M trimmed.

  • Raymond James & Associates's largest Q3 2018 buy was State Street Communication Services Select Sector SPDR ETF: 365,478 shares worth $17.9M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q3 2018, an estimated $155M increase.
  • Raymond James & Associates's biggest Q3 2018 reduction was Sanofi, cutting an estimated $40.1M.
  • Raymond James & Associates fully exited Abaxis Inc in Q3 2018, selling an estimated $10.5M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $64.7B portfolio in Q3 2018.
  • Raymond James & Associates opened 235 new positions and closed 186 in Q3 2018.
  • Raymond James & Associates's portfolio value rose 8.8% quarter-over-quarter to $64.7B.

Based on Raymond James & Associates's 13F filing for Q3 2018, filed 14 Nov 2018.